Summary:
- The article reports on a significant medical breakthrough involving a novel gene-editing therapy developed by researchers at Tel Aviv University to treat aggressive glioblastoma brain tumors.
- The treatment utilizes a CRISPR-based delivery system that targets and destroys the cancer cells' ability to replicate, while simultaneously stimulating an immune response to eliminate the tumor, showing promising results in preclinical models.